Postdoc

Research Group Home Page: 

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
Publications: 

ctDNA monitoring using patient-specific sequencing and integration of variant reads.

E-pub date: 31 May 2020


Detection of ctDNA from Dried Blood Spots after DNA Size Selection.

E-pub date: 31 Mar 2020


Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.

E-pub date: 31 Jan 2020


Detection of ctDNA from dried blood spots after DNA size selection

E-pub date: 31 Aug 2019


High-sensitivity monitoring of ctDNA by patient-specific sequencing panels and integration of variant reads

E-pub date: 31 Aug 2019


Integrated clonal analysis reveals circulating tumor DNA in urine and plasma of glioma patients

E-pub date: 31 Aug 2019


Comprehensive characterisation of cell-free tumour DNA in plasma and urine of patients with renal tumours

E-pub date: 31 Aug 2019


Sensitive detection of ctDNA in low burden and ‘challenging’ cancers

E-pub date: 01 Jul 2019


Improved ctDNA detection in early stage non-small-cell lung cancer

E-pub date: 01 Jul 2019


Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors

E-pub date: 01 Jul 2019


Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology.

E-pub date: 01 Jun 2019


Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models.

E-pub date: 31 Oct 2018


Enhanced detection of circulating tumor DNA by fragment size analysis.

E-pub date: 31 Oct 2018


Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients.

E-pub date: 31 Oct 2018


Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.

E-pub date: 01 Jun 2018


Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.

E-pub date: 31 Jan 2018


Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis.

E-pub date: 01 Oct 2017


Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.

E-pub date: 17 Jul 2017


BRAF and NRAS Locus-Specific Variants Have Different Outcomes on Survival to Colorectal Cancer.

E-pub date: 01 Jun 2017


Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.

E-pub date: 31 May 2017


Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer.

E-pub date: 30 Jun 2016


Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease.

E-pub date: 31 May 2016


Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.

E-pub date: 31 Jul 2015


A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.

E-pub date: 30 Apr 2015


Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.

E-pub date: 27 May 2012


Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

E-pub date: 18 Jun 2011


Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33

E-pub date: 31 Oct 2010


Analysis of the frequency of GNAS codon 201 mutations in advanced colorectal cancer.

E-pub date: 30 Sep 2010


Show all